{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:04:01Z","timestamp":1791605041145,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bioorg.2021.105394","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T13:22:49Z","timestamp":1633008169000},"page":"105394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects"],"prefix":"10.1016","volume":"116","author":[{"given":"Noha H.","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed I.A.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Abdel-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.A.","family":"Abusabaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed T.","family":"El-Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105394_b0005","doi-asserted-by":"crossref","unstructured":"A.H. Abdelazeem, A.G. Safi El-Din, M.M. Abdel-Fattah, N.H. Amin, S.M. El-Moghazy, M.T. El-Saadi, Discovery of novel urea-diarylpyrazole hybrids as dual COX-2\/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks, Eur. J. Med. Chem. 205 (2020) 1-16, 10.1016\/j.ejmech.2020.112662.","DOI":"10.1016\/j.ejmech.2020.112662"},{"key":"10.1016\/j.bioorg.2021.105394_b0010","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/ijms19113285","article-title":"Arachidonic acid metabolites in cardiovascular and metabolic diseases","volume":"19","author":"Sonnweber","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.105394_b0015","first-page":"612","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int. J. Stroke."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4155\/fmc-2017-0153","article-title":"Novel 4-methylsulfonylphenyl derivatives as NSAIDS with preferential COX-2 inhibition","volume":"10","author":"Amin","year":"2018","journal-title":"Future med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2021.105394_b0025","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4155\/fmc-2018-0548","article-title":"New substituted pyrazole derivatives targeting COXs as potential safe anti-inflammatory agents","volume":"11","author":"Abdellatif","year":"2019","journal-title":"Future med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0030","first-page":"2521","article-title":"Anti-inflammatory indomethacin analogs endowed with preferential COX-2 inhibitory activity, Future med","author":"Amin","year":"2018","journal-title":"Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejmech.2014.02.033","article-title":"Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents","volume":"76","author":"Hassan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1068711","article-title":"Role of prostacyclin in the cardiovascular response to thromboxane A2","volume":"296","author":"Cheng","year":"2002","journal-title":"Science."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105394_b0045","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.amjmed.2008.01.045","article-title":"Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs","volume":"121","author":"Jones","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2021.105394_b0050","doi-asserted-by":"crossref","unstructured":"E. Ortiz, Market withdrawal of Vioxx: is it time to rethink the use of COX-2 inhibitors?, J. Manag. Care Pharm. 10 (2004) 551-4, 10.18553\/jmcp.2004.10.6.551.","DOI":"10.18553\/jmcp.2004.10.6.551"},{"key":"10.1016\/j.bioorg.2021.105394_b0055","doi-asserted-by":"crossref","unstructured":"A. Rogers, K. Grieve, T.M. MacDonald In Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research; Bahri, P., Ed.; Springer Singapore: Singapore, 2020, p 131-46. 10.1007\/978-981-15-3013-5_3.","DOI":"10.1007\/978-981-15-3013-5_3"},{"key":"10.1016\/j.bioorg.2021.105394_b0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.62.6.501","article-title":"Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs","volume":"62","author":"Martel-Pelletier","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105394_b0065","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1089\/cmb.2019.0142","article-title":"QSAR classification-based virtual screening followed by molecular docking identification of potential COX-2 inhibitors in a natural product library","volume":"26","author":"Ai","year":"2019","journal-title":"J. Comput. Biol."},{"issue":"7-8","key":"10.1016\/j.bioorg.2021.105394_b0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","article-title":"Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs","volume":"38","author":"Charlier","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105394_b0075","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105394_b0080","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jm201468j","article-title":"Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications","volume":"55","author":"Shen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0085","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2007.08.002","article-title":"DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation","volume":"28","author":"Fleming","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2021.105394_b0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105394_b0100","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ijcard.2012.03.167","article-title":"A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPAR\u03b3 to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction","volume":"167","author":"Xu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioorg.2021.105394_b0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.apha.2016.04.003","article-title":"Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function","volume":"77","author":"Imig","year":"2016","journal-title":"Adv. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105394_b0110","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.chest.2016.10.058","article-title":"Mechanisms of vascular dysfunction in COPD and effects of a novel soluble epoxide hydrolase inhibitor in smokers","volume":"151","author":"Yang","year":"2017","journal-title":"Chest."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105394_b0115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bcp.12855","article-title":"Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor","volume":"81","author":"Lazaar","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105394_b0120","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.jmedchem.0c01886","article-title":"Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative","volume":"64","author":"Hammock","year":"2021","journal-title":"J. Med. Chem."},{"issue":"Suppl","key":"10.1016\/j.bioorg.2021.105394_b0125","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bioorg.2021.105394_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmc.2020.115735","article-title":"Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain","volume":"28","author":"Lee","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.pharmtox.45.120403.095920","article-title":"Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles","volume":"45","author":"Morisseau","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2021.105394_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/JPR.S241893","article-title":"Inhibition of the soluble epoxide hydrolase as an analgesic strategy: A review of preclinical evidence","volume":"14","author":"Wang","year":"2021","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/acs.jmedchem.0c01507","article-title":"Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products","volume":"64","author":"Sun","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25235488","article-title":"Small molecule soluble epoxide hydrolase inhibitors in multitarget and combination therapies for inflammation and cancer","volume":"25","author":"Das Mahapatra","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2021.105394_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2020.104165","article-title":"Development of multitarget inhibitors for the treatment of pain: Design, synthesis, biological evaluation and molecular modeling studies","volume":"103","author":"Wilt","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2021.105394_b0160","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1021\/jm500694p","article-title":"Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy","volume":"57","author":"Lee","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.prostaglandins.2013.02.001","article-title":"In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor","volume":"104\u2013105","author":"Podolin","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105394_b0170","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.bmc.2015.03.083","article-title":"Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening","volume":"23","author":"Amano","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0175","doi-asserted-by":"crossref","unstructured":"A. Kuppusamy, L. Tangella, U. M, S. Thirumalaisamy, V. Subhadradevi, P. Jagannath, M. Arumugam, In vitro soluble epoxide hydrolase enzyme inhibitory activity of some novel chalcone derivatives, Int. J. Phytopharm. 2 (2012) 116-21, 10.7439\/ijpp.v2i4.705.","DOI":"10.7439\/ijpp.v2i4.705"},{"key":"10.1016\/j.bioorg.2021.105394_b0180","first-page":"51","article-title":"Design, synthesis and biological evaluation of 4-benzamidobenzoic acid hydrazide derivatives as novel soluble epoxide hydrolase inhibitors, Iran","volume":"13","author":"Zavareh","year":"2014","journal-title":"J. Pharm. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105394_b0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/cmdc.201300057","article-title":"From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties","volume":"8","author":"Buscat\u00f3","year":"2013","journal-title":"ChemMedChem."},{"issue":"sup2","key":"10.1016\/j.bioorg.2021.105394_b0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/14756366.2016.1189421","article-title":"Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach","volume":"31","author":"Jo","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105394_b0195","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00044-017-2096-2","article-title":"Soluble epoxide hydrolase inhibitory activity of phenolic glycosides from Polygala tenuifolia and in silico approach","volume":"27","author":"Vinh","year":"2018","journal-title":"Med. Chem. Res."},{"issue":"13","key":"10.1016\/j.bioorg.2021.105394_b0200","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.bmcl.2009.05.036","article-title":"Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors","volume":"19","author":"Shen","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105394_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22010013","article-title":"The multifaceted role of epoxide hydrolases in human health and disease","volume":"22","author":"Gautheron","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105394_b0210","doi-asserted-by":"crossref","first-page":"1800030","DOI":"10.1002\/ardp.201800030","article-title":"Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity","volume":"351","author":"Nandha","year":"2018","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"20","key":"10.1016\/j.bioorg.2021.105394_b0215","doi-asserted-by":"crossref","first-page":"11498","DOI":"10.1021\/acs.jmedchem.0c00561","article-title":"Design, synthesis, and structure-activity relationship studies of dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase","volume":"63","author":"Hiesinger","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105394_b0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bmcl.2012.11.084","article-title":"Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors","volume":"23","author":"Pecic","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0225","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/13880209.2017.1299768","article-title":"Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model","volume":"55","author":"Ahmad","year":"2017","journal-title":"Pharm. Biol."},{"issue":"6610","key":"10.1016\/j.bioorg.2021.105394_b0230","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature."},{"key":"10.1016\/j.bioorg.2021.105394_b0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem."},{"key":"10.1016\/j.bioorg.2021.105394_b0240","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1016\/j.bmcl.2010.07.054","article-title":"The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105394_b0245","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/jm301617j","article-title":"Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase","volume":"56","author":"Meirer","year":"2013","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105394_b0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/acs.jcim.5b00592","article-title":"Discovery of potent soluble epoxide hydrolase (sEH) inhibitors by pharmacophore-based virtual screening","volume":"56","author":"Waltenberger","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2021.105394_b0255","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bioorg.2018.02.018","article-title":"Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile","volume":"77","author":"Abdellatif","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2021.105394_b0260","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.1016\/j.bmc.2009.10.035","article-title":"Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents","volume":"17","author":"Bandgar","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105394_b0265","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3109\/14756366.2016.1158168","article-title":"Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophore","volume":"31","author":"Abdellatif","year":"2016","journal-title":"J Enzyme Inhib Med Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0270","first-page":"1","article-title":"Synthesis and reactions of 5-phenylpyrido-[3,2-d]-pyridazin-8(7H)-one derivatives","volume":"5","author":"Yassin","year":"2013","journal-title":"Der Pharma Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0275","first-page":"53","article-title":"Improved Fischer Esterification of Substituted Benzoic Acid under Sealed-Vessel Microwave Condition","volume":"26","author":"Abdul Rahim","year":"2015","journal-title":"J. Phys. Sci."},{"key":"10.1016\/j.bioorg.2021.105394_b0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2016.08.033","article-title":"Design, synthesis and pharmacological evaluation of new anti-inflammatory compounds","volume":"791","author":"Cidade","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105394_b0285","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rats as an assay for antiinflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105394_b0290","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/jmf.2008.0133","article-title":"Pro-inflammatory enzymes, cyclooxygenase 1, cyclooxygenase 2, and 5-lipooxygenase, inhibited by stabilized rice bran extracts","volume":"12","author":"Roschek","year":"2009","journal-title":"J. Med. food."},{"issue":"2-3","key":"10.1016\/j.bioorg.2021.105394_b0295","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0005-2760(92)90297-9","article-title":"Mammalian lipoxygenases: molecular structures and functions","volume":"1128","author":"Yamamoto","year":"1992","journal-title":"Biochim. Biophys. Acta."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105394_b0300","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.ejmech.2008.02.034","article-title":"Synthesis and pharmacological evaluation of 2-substituted benzo [b] thiophenes as anti-inflammatory and analgesic agents","volume":"44","author":"Fakhr","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"37","key":"10.1016\/j.bioorg.2021.105394_b0305","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1073\/pnas.0605908103","article-title":"Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors","volume":"103","author":"Schmelzer","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.bioorg.2021.105394_b0310","first-page":"155","article-title":"Ameliorative effect of beraprost sodium on celecoxib induced cardiotoxicity in rats, Iran","volume":"17","author":"Ahmad","year":"2018","journal-title":"J. Pharm. Res."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105394_b0315","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9149(98)00200-8","article-title":"Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies","volume":"81","author":"Olatidoye","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105394_b0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.phrs.2004.03.004","article-title":"Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats","volume":"50","author":"SABEENAFARVIN","year":"2004","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0325","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2009.10.022","article-title":"Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure","volume":"159","author":"Tsutamoto","year":"2010","journal-title":"Am. heart J."},{"key":"10.1016\/j.bioorg.2021.105394_b0330","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2016.06.042","article-title":"The protective role of neuregulin-1: a potential therapy for sepsis-induced cardiomyopathy","volume":"788","author":"Zhou","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105394_b0335","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1007\/s10620-007-9788-2","article-title":"Role of oxidative stress in celecoxib-induced renal damage in wistar rats","volume":"52","author":"Gupta","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bioorg.2021.105394_b0340","first-page":"66","article-title":"The role of prostacyclin in vascular tissue","volume":"38","author":"Moncada","year":"1979","journal-title":"Fed. Proc."},{"key":"10.1016\/j.bioorg.2021.105394_b0345","unstructured":"https:\/\/www.rcsb.org\/structure\/3LN1."},{"key":"10.1016\/j.bioorg.2021.105394_b0350","unstructured":"https:\/\/www.rcsb.org\/structure\/6YL4."},{"key":"10.1016\/j.bioorg.2021.105394_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105394_b0360","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0365","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/14756366.2021.1901089","article-title":"Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"36","author":"Kassab","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105394_b0375","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0380","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1515\/acph-2015-0014","article-title":"Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation","volume":"65","author":"Ali","year":"2015","journal-title":"Acta Pharm."},{"key":"10.1016\/j.bioorg.2021.105394_b0385","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1039\/c3sm50268f","article-title":"Tunable pH and temperature response of weak polyelectrolyte brushes: role of hydrogen bonding and monomer hydrophobicity","volume":"9","author":"Lu","year":"2013","journal-title":"Soft Matter."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105394_b0390","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/mz400413v","article-title":"Molecular Weight Dependence of Polymer Chain Mobility within Multilayer Films","volume":"2","author":"Xu","year":"2013","journal-title":"ACS Macro Letters."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105394_b0395","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1021\/acsabm.9b00381","article-title":"Electrostatically Assembled Multilayered Films of Biopolymer Enhanced Nanocapsules for on-Demand Drug Release","volume":"2","author":"Xu","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105394_b0400","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acsapm.9b01051","article-title":"Temperature-Responsive Multilayer Films of Micelle-Based Composites for Controlled Release of a Third-Generation EGFR Inhibitor","volume":"2","author":"Xu","year":"2020","journal-title":"ACS Appl. Polym. Mater."},{"key":"10.1016\/j.bioorg.2021.105394_b0405","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bioorg.2018.02.018","article-title":"Non-acidic 1, 3, 4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile","volume":"77","author":"Abdellatif","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0410","first-page":"359","article-title":"Synthesis and antimicrobial activity of some 1-(2, 4-dinitrophenyl)-3-(3-nitrophenyl)-5-(4-substituted phenyl)-4-bromo-2-pyrazolines and 1-(2, 4-dinitrophenyl)-3-(3-nitrophenyl)-5-(4-substituted phenyl)-2-pyrazolin-4-ones","volume":"64","author":"Mishra","year":"2007","journal-title":"Acta. Pol. Pharm."},{"key":"10.1016\/j.bioorg.2021.105394_b0415","doi-asserted-by":"crossref","unstructured":"X.Y. Qiu, S.Z. Li, A.R. Shi In Advanced Materials Research; Trans Tech Publ: 2012; Vol. 518, p 255-60.","DOI":"10.4028\/www.scientific.net\/AMR.518-523.255"},{"key":"10.1016\/j.bioorg.2021.105394_b0420","first-page":"754","article-title":"Antimicrobial activity of some novel synthesized heterocyclic compounds from substituted chalcones","volume":"2","author":"Balaji","year":"2010","journal-title":"J. Chem. Pharm. Res."},{"key":"10.1016\/j.bioorg.2021.105394_b0425","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3797\/scipharm.1204-27","article-title":"Synthesis and biological evaluation of some novel 2-mercaptobenzothiazoles carrying 2-pyrazoline","volume":"80","author":"Azam","year":"2012","journal-title":"Sci. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105394_b0430","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF03246113","article-title":"Synthesis and kinetic resolution of furyl substituted secondary carbinols by porcine pancreatic lipase under solvent free conditions","volume":"5","author":"Mamaghani","year":"2008","journal-title":"J. Iran Chem. Soc."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105394_b0435","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ejmech.2011.01.060","article-title":"Synthesis and biological evaluation of some 4-functionalized-pyrazoles as antimicrobial agents","volume":"46","author":"Sharma","year":"2011","journal-title":"Eur. J Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105394_b0440","unstructured":"B.S. Furniss Vogel's textbook of practical organic chemistry; Pearson Education India, 1989."},{"issue":"3-4","key":"10.1016\/j.bioorg.2021.105394_b0445","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000438705","article-title":"Assessment of the mechanistic role of cinnarizine in modulating experimentally-induced bronchial asthma in rats","volume":"96","author":"Abdel-Fattah","year":"2015","journal-title":"Pharmacology."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105394_b0450","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/phrs.1999.0630","article-title":"The protective effect of glutathione administration on adriamycin-induced acute cardiac toxicity in rats","volume":"42","author":"Mohamed","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2021.105394_b0455","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0022-2828(89)90680-9","article-title":"Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients","volume":"21","author":"Katus","year":"1989","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bioorg.2021.105394_b0460","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(94)90156-2","article-title":"Tumor necrosis factor (TNF) \u03b1 quantification by ELISA and bioassay: effects of TNF\u03b1-soluble TNF receptor (p55) complex dissociation during assay incubations","volume":"177","author":"Corti","year":"1994","journal-title":"J. immunol. Methods."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105394_b0465","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0090-6980(86)90103-6","article-title":"An enzyme-linked immunosorbent assay for 6-keto PGF","volume":"31","author":"Docherty","year":"1986","journal-title":"Prostaglandins."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0470","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-8981(72)90254-9","article-title":"A rapid ultraviolet spectrophotometric lactic dehydrogenase assay","volume":"40","author":"Martinek","year":"1972","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.bioorg.2021.105394_b0475","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/clinchem\/21.11.1612","article-title":"New manual and automated method for determining activity of creatine kinase isoenzyme MB, by use of dithiothreitol: Clinical applications","volume":"21","author":"Rao","year":"1975","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105394_b0480","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1054-8807(03)00107-8","article-title":"Structural and molecular pathology of the heart in Carvajal syndrome","volume":"13","author":"Kaplan","year":"2004","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.bioorg.2021.105394_b0485","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0253-7613.106434","article-title":"Cardioprotective effect of Saraca indica against cyclophosphamide induced cardiotoxicity in rats: A biochemical, electrocardiographic and histopathological study","volume":"45","author":"Swamy","year":"2013","journal-title":"Indian J. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821007719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:35:04Z","timestamp":1758616504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821007719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":97,"alternative-id":["S0045206821007719"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105394","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105394"}}